blue4u
QMengColdJoke
:
The previous HBV clinical data were good. They were all 60-70, so the antibodies were not yet on the market. On the other hand, the effectiveness of COVID-19 antibodies can still decline; the market is clearly underestimated
QMengColdJoke
blue4u
:
This is ridiculous . Caught up with the agency's frenzied shorting of small pharmaceuticals. I misoperated along the way. So I can only continue to carry it hard
102355763 : Bullish only if the new variant is even more contagious than Omicron n more deadly than any of the earlier strains
QMengColdJoke : Vir isn't as cheap now; scale down. Unfortunately, I've already bought a lot (this kind of need to control positions).
blue4u QMengColdJoke : The previous HBV clinical data were good. They were all 60-70, so the antibodies were not yet on the market. On the other hand, the effectiveness of COVID-19 antibodies can still decline; the market is clearly underestimated
QMengColdJoke blue4u : This is ridiculous . Caught up with the agency's frenzied shorting of small pharmaceuticals. I misoperated along the way. So I can only continue to carry it hard
blue4u QMengColdJoke : US stocks generally fell today, and the epidemic was severe, only vaccine stocks rose